Published in Eur J Surg Oncol on October 06, 2013
The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg (2014) 1.00
Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol (2015) 0.88
Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol (2017) 0.75
Surgical resection of a liver metastasis from breast cancer. Ann R Coll Surg Engl (2015) 0.75
Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study). BMC Cancer (2015) 0.75
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet (1992) 5.49
BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res (1997) 2.77
Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys (2000) 2.58
Association of p53 mutations with short survival in colorectal cancer. Gastroenterology (1994) 2.19
High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology (2000) 2.06
Recurrence in the axilla after sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol (2002) 2.03
Survival and acquired genetic alterations in colorectal cancer. Gastroenterology (1992) 2.02
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet (1997) 1.91
Multiple genetic alterations in distal and proximal colorectal cancer. Lancet (1989) 1.87
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol (2013) 1.82
Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.68
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer (1994) 1.60
Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae. Clin Infect Dis (1999) 1.60
Carotid and vertebral artery dissections: three-dimensional time-of-flight MR angiography and MR imaging versus conventional angiography. Radiology (1994) 1.55
In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol (1983) 1.49
Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature. Eur J Cancer (2004) 1.47
[Fast track rehabilitation in colonic surgery]. Ann Fr Anesth Reanim (2007) 1.38
Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol (2010) 1.35
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res (2000) 1.24
Cabazitaxel in patients with advanced solid tumours: results of a Phase I and pharmacokinetic study. Eur J Cancer (2012) 1.19
Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology (1994) 1.19
Heterogeneity of insulin action in muscle: influence of blood flow. Am J Physiol (1986) 1.17
Oncoplastic breast surgery: a review and systematic approach. J Plast Reconstr Aesthet Surg (2009) 1.16
[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]. Cancer Radiother (2009) 1.15
Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer (1992) 1.13
Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer (2008) 1.13
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience. Ann Oncol (2010) 1.12
Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene (1995) 1.12
The muscle-sparing latissimus dorsi flap for breast reconstruction. Plast Reconstr Surg (2009) 1.11
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol (2009) 1.11
Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg (1995) 1.11
Tongue protrusion strength and fatiguability: relationship to apnoea/hypopnoea index and age. J Sleep Res (2000) 1.10
Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet (1990) 1.08
Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int J Cancer (1988) 1.08
Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer (1990) 1.07
Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. Int J Radiat Oncol Biol Phys (2001) 1.07
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer (1995) 1.07
A semiparametric approach for the two-sample comparison of survival times with long-term survivors. Biometrics (2001) 1.05
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol (1998) 1.05
[Malignant-like angiomyolipoma of the liver: report of one case and review of the literature]. Ann Chir (2005) 1.04
[Hepatic resection for breast cancer metastases: results and prognosis (65 cases)]. Ann Chir (2001) 1.04
[Leiomyosarcoma of the middle segment of the inferior vena cava: tactical problems raised by renal and caval revascularisation]. J Mal Vasc (2006) 1.01
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa. J Neurooncol (2013) 1.01
Consistent deficiencies of chromosome 18 and of the short arm of chromosome 17 in eleven cases of human large bowel cancer: a possible recessive determinism. Ann Genet (1985) 1.00
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues. J Clin Pathol (2007) 0.99
Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer (1994) 0.99
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer. Eur J Cancer (2000) 0.98
[Etiologic spectrum of mesenteric panniculitis: report of 7 cases]. Rev Med Interne (2007) 0.97
Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer (1995) 0.97
Carcinoid tumor of the common bile duct. Am J Gastroenterol (1981) 0.96
Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. Eur J Surg Oncol (1998) 0.95
Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int J Cancer (1991) 0.94
Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. Breast Cancer Res Treat (1999) 0.94
Existence of two distinct processes of chromosomal evolution in near-diploid colorectal tumors. Cancer Genet Cytogenet (1988) 0.94
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. J Clin Oncol (1996) 0.94
The relevance of image quality indices for dose optimization in abdominal multi-detector row CT in children: experimental assessment with pediatric phantoms. Phys Med Biol (2009) 0.93
Characteristic chromosomal imbalances in 18 near-diploid colorectal tumors. Cancer Genet Cytogenet (1987) 0.93
p53 from basic research to clinical applications. Crit Rev Oncog (1992) 0.93
Abdominoperineal resection for anal cancer. Dis Colon Rectum (2008) 0.93
Management of exposed, infected implant-based breast reconstruction and strategies for salvage. J Plast Reconstr Aesthet Surg (2011) 0.92
Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology (2001) 0.91
Male pattern baldness and the risk of prostate cancer. Ann Oncol (2011) 0.90
Hepatic regenerating nodules: a mimic of recurrent cancer in children. Pediatr Radiol (2000) 0.89
Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Eur J Surg Oncol (2009) 0.89
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. Eur J Cancer Clin Oncol (1989) 0.88
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents. Br J Cancer (2012) 0.87
Treatment of epidermoid anal canal cancer. Am J Surg (1984) 0.87
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta. Eur J Cancer (1996) 0.87
[Malignant hereditary paraganglioma: problems raised by non-functional forms management]. Ann Chir (2006) 0.87
Mammary tuberculosis. Lancet (1982) 0.87
[Mammoplasty combined with irradiation: conservative treatment of breast cancer localized in the lower quadrant]. Ann Chir Plast Esthet (1990) 0.86
Efficiency of orthotopic xenograft models for human colon cancers. In Vivo (1997) 0.86
Management of penetrating abdominal vessel injuries. J Visc Surg (2010) 0.86
Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene (1993) 0.86
DNA-repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements. Genes Chromosomes Cancer (1995) 0.86
Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification? Ann Surg Oncol (2001) 0.85
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours. Br J Cancer (2005) 0.85
Cytogenetic study of 30 colorectal adenomas. Cancer Genet Cytogenet (1994) 0.85
Purification and characterization of multiple forms of the pineapple-stem-derived cysteine proteinases ananain and comosain. Biochem J (1994) 0.85
Prognosis of cloacogenic and squamous cancers of the anal canal. Dis Colon Rectum (1986) 0.85
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab. Ann Oncol (2011) 0.85
Intraabdominal desmoplastic small round cell tumor: report of a case with fine needle aspiration, cytologic diagnosis and molecular confirmation. Acta Cytol (2001) 0.84
Recurrent deletions of chromosomes 11q and 3p in anal canal carcinoma. Int J Cancer (1987) 0.84
Pleomorphic adenoma. Am J Surg Pathol (1998) 0.84
[Prevention of postoperative lymphocele after breast amputation]. Presse Med (1985) 0.84
Vacuum-assisted large-core needle biopsy (VLNB) improves the management of patients with breast microcalcifications - analysis of 1009 cases. Eur J Surg Oncol (2007) 0.84
Clinically aggressive metastasizing pleomorphic adenoma: report of two cases. Head Neck (1997) 0.83
DNA content and genetic evolution of human colorectal adenocarcinoma. A study by flow cytometry and cytogenetic analysis. Int J Cancer (1988) 0.83
Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients. Ann Oncol (2011) 0.83
Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy. Br J Radiol (2009) 0.83
Management of fetal thyroid goitres: a report of 11 cases in a single perinatal unit. Prenat Diagn (2000) 0.82
Preservation versus section of intercostal-brachial nerve (IBN) in axillary dissection for breast cancer--a prospective randomized trial. Eur J Surg Oncol (1998) 0.82
Investigation of sequence homology in a group of type-II restriction/modification isoschizomers. Gene (1988) 0.82
Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol (2011) 0.82
Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population. Hum Genet (1991) 0.81
Analyzing prognostic factors in breast cancer using a multistate model. Breast Cancer Res Treat (1999) 0.81